Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Bold Eagle Acquisition | BEAG | Mar 17, 2025 | 10.04 | 0.00 |
Bold Eagle Acquisition Unit | BEAGU | Mar 17, 2025 | 10.27 | 0.00 |
Bolt Biotherapeutics | BOLT | Mar 17, 2025 | 0.41 | -0.94 |
Bolt Projects | BSLK | Mar 17, 2025 | 0.33 | -0.39 |
Bon Natural Life | BON | Mar 17, 2025 | 0.61 | -57.46 |
Bone Biologics | BBLG | Mar 17, 2025 | 0.83 | +0.29 |
Booking | BKNG | Mar 17, 2025 | 4 563.39 | +2.19 |
Boot Barn | BOOT | Mar 17, 2025 | 103.92 | +2.07 |
Booz Allen Hamilton | BAH | Mar 17, 2025 | 115.34 | +2.75 |
Boqii ADR | BQ | Mar 17, 2025 | 2.59 | +22.17 |
Borealis Foods A | BRLS | Mar 17, 2025 | 5.80 | -2.44 |
BorgWarner | BWA | Mar 17, 2025 | 28.35 | -1.22 |
Borr Drilling | BORR | Mar 17, 2025 | 2.28 | +1.33 |
Boston Beer | SAM | Mar 17, 2025 | 228.19 | -0.29 |
Boston Omaha | BOC | Mar 17, 2025 | 14.00 | +0.36 |
Boston Properties | BXP | Mar 17, 2025 | 68.64 | +4.78 |
Boston Scientific | BSX | Mar 17, 2025 | 98.90 | +1.79 |
Boundless Bio | BOLD | Mar 17, 2025 | 1.68 | 0.00 |
Bowen Acquisition | BOWN | Mar 17, 2025 | 4.17 | +6.11 |
Bowhead Specialty | BOW | Mar 17, 2025 | 36.52 | +3.16 |
Bowman Consulting | BWMN | Mar 17, 2025 | 23.21 | -0.34 |
Box A | BOX | Mar 17, 2025 | 30.99 | -0.80 |
Boxlight | BOXL | Mar 17, 2025 | 1.48 | +4.96 |
Boyd Gaming | BYD | Mar 17, 2025 | 69.40 | +1.33 |
BP ADR | BP | Mar 17, 2025 | 33.76 | +1.11 |
BP Prudhoe Bay Royalty Trust Unit | BPT | Mar 17, 2025 | 0.61 | +4.99 |
Brady | BRC | Mar 17, 2025 | 71.97 | +1.74 |
Braemar Hotels & Resorts | BHR | Mar 17, 2025 | 3.00 | +1.69 |
Braemar Hotels & Resorts B Pref | BHR-B | Mar 17, 2025 | 14.18 | -0.84 |
Braemar Hotels & Resorts D Pref | BHR-D | Mar 17, 2025 | 20.38 | -0.56 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.